T2 Biosystems Seals $23M Series D
Lexington, Mass.-based T2 Biosystems has closed a $23 million Series D financing round led by new investor Aisling Capital. Return backers Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners, Physic Ventures, Partners Healthcare, Arcus Ventures, RA Capital, Camros Capital and WS Investments also contributed. The money will help with ongoing development and clinical trials of the company’s diagnostic technology.
10 August 2011•3 mins read
